Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks

BioGaia

Market Cap: SEK 12.1b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Vitrolife

Market Cap: SEK 12.1b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

AddLife

Market Cap: SEK 20.8b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

Camurus

Market Cap: SEK 32.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 13.6b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BioArctic

Market Cap: SEK 27.5b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Swedish Orphan Biovitrum

Market Cap: SEK 162.5b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.